Dendrobii Officinalis, a traditional Chinese edible and officinal plant, accelerates liver recovery by regulating the gut-liver axis in NAFLD mice

Dendrobii Officinalis, a traditional Chinese edible and officinal plant, accelerates liver recovery by regulating the gut-liver axis in NAFLD mice

Dendrobii Officinalis (DOF) is a Traditional Chinese edible and bioavailable plant. The aim of this study was to investigate the hepatoprotective effects of DOF ultrafine powder (DOFP) and its underlying molecular mechanisms in nonalcoholic fatty liver disease (NAFLD) mice after they were withdrawn...

Full description

Bibliographic Details
Main Authors:	Shan-Shan Lei, Bo Li, Ye-Hui Chen, Xinglishang He, Yu-Zhi Wang, Huan-Huan Yu, Fu-Chen Zhou, Xiang Zheng, Xue Chen, Ning-Yu Zhang, Jie Su, Mei-Qiu Yan, Gui-Yuan Lv, Su-Hong Chen
Format:	Article
Language:	English
Published:	Elsevier 2019-10-01
Series:	Journal of Functional Foods
Subjects:	Dendrobii Officinalis Ultrafine powder Nonalcoholic fatty liver disease (NAFLD) Gut-liver axis LPS TLR4
Online Access:	http://www.sciencedirect.com/science/article/pii/S1756464619303822

Similar Items

Suitability evaluation on material specifications and edible methods of Dendrobii Officinalis Caulis based on holistic polysaccharide marker
by: Zi-Jun Cao, et al.
Published: (2020-05-01)

Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study
by: Fang Liu, et al.
Published: (2018-09-01)

An improved deep learning network for image detection and its application in Dendrobii caulis decoction piece
by: Yonghu Chang, et al.
Published: (2024-06-01)

Comparison of liver enzymes and sonological grading in nonalcoholic fatty liver
by: Bishnu Jwarchan, et al.
Published: (2020-03-01)

Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD)
by: Naveen Kalra, et al.
Published: (2009-01-01)

Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
by: Rodrigo Bremer Nones, et al.
Published: (2017-02-01)

Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy
by: Yu Gao, et al.
Published: (2020-09-01)

The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
by: Jiayi Liu, et al.
Published: (2022-08-01)

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Min-Sun Kwak, et al.
Published: (2012-12-01)

Comparative Transcriptomics Analyses in Livers of Mice, Humans, and Humanized Mice Define Human-Specific Gene Networks
by: Chengfei Jiang, et al.
Published: (2020-11-01)

The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)
by: Amanda Hanson, et al.
Published: (2018-08-01)

Antinociceptive Effect of <i>Dendrobii caulis</i> in Paclitaxel-Induced Neuropathic Pain in Mice
by: Keun Tae Park, et al.
Published: (2023-11-01)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
by: Tina Reinson, et al.
Published: (2023-02-01)

Dietary inflammatory index in relation to the progression of hepatic steatosis and liver fibrosis: evaluation by elastography/Fibroscan
by: Mahsa Miryan, et al.
Published: (2024-04-01)

Bavachinin protects the liver in NAFLD by promoting regeneration via targeting PCNA
by: Xi Dong, et al.
Published: (2024-01-01)

Prevalence of Non Alcoholic Fatty Liver Disease (NAFLD) among Adults Aged 30 Years and Above in a Rural Population of Jammu- An Observational Study
by: Anuj Kapoor, et al.
Published: (2018-11-01)

Triglycerides mediate the relationships of per- and poly-fluoroalkyl substance (PFAS) exposure with nonalcoholic fatty liver disease (NAFLD) risk in US participants
by: Wenying Qiao, et al.
Published: (2025-01-01)

Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
by: Menooa Ebrahimi, et al.
Published: (2023-03-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

The Role of Vitamin E in the Treatment of NAFLD
by: Brandon J. Perumpail, et al.
Published: (2018-09-01)

Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression
by: Youlian Zhou, et al.
Published: (2018-12-01)

Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014
by: Jennifer K. Frediani, et al.
Published: (2018-01-01)

Dietary Selenium Alleviated Mouse Liver Oxidative Stress and NAFLD Induced by Obesity by Regulating the KEAP1/NRF2 Pathway
by: Yi Wang, et al.
Published: (2022-02-01)

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
by: Brandon J. Perumpail, et al.
Published: (2019-02-01)

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
by: Juan Pablo Arab, et al.
Published: (2020-11-01)

Effects of Rhinacanthins-rich Extract from Rhinacanthus nasutus on Nonalcoholic Fatty Liver Rats Induced by High Fat Diet
by: Zhiqiang GONG, et al.
Published: (2023-01-01)

Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)
by: Adnan Khan, et al.
Published: (2022-10-01)

Low muscle quality index is associated with increased risk of advanced fibrosis in adult patients with nonalcoholic fatty liver disease: NHANES 2011–2014
by: Xinxing Tantai, et al.
Published: (2024-08-01)

Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease
by: Margalida Monserrat-Mesquida, et al.
Published: (2020-08-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

Determination of Frequency of Diabetes and Pre-Diabetes in Patients with Nonalcoholic Fatty Liver Disease and Comparison with a Control Group
by: Bahram Pakzad, et al.
Published: (2016-03-01)

NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study
by: Renling Yao, et al.
Published: (2024-01-01)

Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials
by: Hawal Lateef Fateh, et al.
Published: (2023-08-01)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
by: Giovanni Targher
Published: (2020-10-01)

Association of the p.I148m polymorphism in the <i>PNPLA3</i> gene with the severity of nonalcoholic fatty liver disease in various clinical groups
by: D. V. Sidorenko, et al.
Published: (2024-04-01)

Metabolic Syndrome and Nonalcoholic Fatty Liver Disease: Nutritional Approach for Prevention
by: Zamzam Paknahad, et al.
Published: (2013-11-01)

Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
by: Panyavee Pitisuttithum, et al.
Published: (2020-04-01)

From NAFLD to Chronic Liver Diseases. Assessment of Liver Fibrosis through Non-Invasive Methods before Liver Transplantation: Can We Rely on Them?
by: Pasquale Auricchio, et al.
Published: (2023-05-01)

Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery
by: Marielle Malucelli, et al.
Published: (2023-11-01)

Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content
by: Haoxiang Zhu, et al.
Published: (2025-01-01)